C-Peptide (57-87) human

Product Name
C-Peptide (57-87) human, EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ
Product Description

C-Peptide (human) Trifluoroacetate is a synthetic version of the human proinsulin connecting peptide, commonly referred to as C-peptide. This peptide plays a crucial role in insulin production, where it links the A and B chains of proinsulin. During insulin biosynthesis, C-peptide is enzymatically cleaved from proinsulin in the pancreas, releasing both C-peptide and insulin (composed of the A and B chains bonded together) into the bloodstream in equimolar amounts.

Applications in Research and Clinical Trials

C-peptide (human) is a highly valuable biomarker for assessing endogenous insulin secretion, making it indispensable in both clinical diagnostics and research settings. The measurement of C-peptide under standardized conditions offers a sensitive and clinically validated method for evaluating beta-cell function in the pancreas, especially in patients with type 1 diabetes. It is the primary outcome measure in clinical trials aimed at preserving or enhancing endogenous insulin production in these patients.

Influence on Physiological Conditions

Beyond its role as a biomarker, C-peptide has been shown to influence a variety of physiological conditions related to diabetes, including neuropathy, nephropathy, and encephalopathy. Clinical studies have demonstrated that C-peptide can ameliorate and even reverse the degrading effects of diabetic neuropathy, providing therapeutic potential for addressing these complications. This hormonal activity suggests that C-peptide administration may have broader applications in managing diabetes-related conditions.

Significance in Drug Development

In drug development, particularly for diabetes treatments, C-peptide serves as a crucial indicator of beta-cell function, helping to evaluate the efficacy of therapies aimed at preserving the body’s natural insulin production. Its ability to mitigate complications associated with diabetes, such as kidney and nerve dysfunctions, positions it as a promising candidate for therapeutic interventions beyond its traditional diagnostic use.

Molecular and Storage Information

The peptide has the molecular formula C129H211N35O48 and a molecular weight of 3020.30 g/mol. It is available as a trifluoroacetate salt, which enhances its solubility and stability for research applications. Proper storage at temperatures below -15°C is essential to maintain the peptide’s integrity.

This peptide is crucial for researchers focusing on diabetes, pancreatic disorders, and related fields, providing a reliable tool for both diagnostic and therapeutic research applications.

Product Quantity
1mg
Purity
>95%
Catalog Number
LT8200
Molecular Weight
3020.30
Formula
C129H211N35O48
Sequence
CAS# 33017-11-7, EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ, H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH
  • 4 Units in Stock

Ask a Question

$250.00

Add to Cart:
LifeTein LifeTein provides custom peptide synthesis service, recombinant proteins, peptides, cytokines, custom antibody service and custom protein service. LifeTein is the world leader in fast peptide synthesis service with lab facility located in New Jersey USA. LifeTein Logo 100 Randolph Road, Suite 2D, Somerset USA New Jersey 08873
Copyright © 2024 LifeTein.com. Powered by LifeTein